Broad Pipeline of Differentiated
Product Candidates
to Fight Cancer & Autoimmune Disorders
Breakthrough Biologics,
Leading Multispecific Antibody
Technology Platforms
and Protein Engineering Expertise
Fully-integrated, Antibody-based
Development Capabilities,
Including GMP Manufacturing
Focused on Developing
Innovative Medicines
for Patients with Unmet Needs
Breakthrough Biologics,

We are a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, autoimmune disorders and infectious diseases.

Corporate Fact Sheet

We’re Hiring!

Our success depends on the talent and dedication of the staff we hire. We are continually expanding our network of individuals who are excited about making a difference in the lives of patients.

Latest News

MacroGenics Enters Collaboration and License Agreement with Janssen to Develop New DART Molecule for Treatment of Cancer
Read More

MacroGenics to Present MGD010 Clinical Data at EULAR 2016
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close